The role of JNK phosphorylation as a molecular target to enhance adenovirus replication, oncolysis and cancer therapeutic efficacy

References

• Bischoff, J. R., Kirn D.H, Williams A., Heise C., Horn S., Muna M., Ng L., Nye J. A., Sampson-Johannes A., Fattaey A., McCormick F. An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science. 1996; 274(5286):373–376.
   PubMed Web of Science ®Google Scholar
• Cheng PH, Lian S, Zhao R, Rao XM, McMasters KM, Zhou HS. 2013. Combination of autophagy inducer rapamycin and oncolytic adenovirus improves antitumor effect in cancer cells. Virol J. 10:293. doi:10.1186/1743-422X-10-293.
   PubMed Web of Science ®Google Scholar
• Cheng PH, Rao XM, McMasters KM, Zhou HS. Molecular basis for viral selective replication in cancer cells: activation of CDK2 by adenovirus-induced cyclin E. PloS One. 2013;8(2):e57340. doi:10.1371/journal.pone.0057340.
   PubMed Web of Science ®Google Scholar
• Khuri, F. R., Nemunaitis J., Ganly I., Arseneau J., Tannock I. F., Romel. L., Gore M., Ironside J., MacDougall R. H., Heise C., Randlev B., Gillenwater A. M., Bruso P., Kaye S. B., Hong W. K., Kirn D. H. A controlled trial of intratumoral ONYX-015, a selectively-replicating adenovirus, in combination with cisplatin and 5-fluorouracil in patients with recurrent head and neck cancer. Nat Med. 2000;6(8):879–885. doi:10.1038/78638.
   PubMed Web of Science ®Google Scholar
• Nemunaitis J., Cunningham C., Buchanan A., Blackburn A., Edelman G., Maples P., Netto G., Tong A., Randlev B., Olson S., Kirn D. Intravenous infusion of a replication-selective adenovirus (ONYX-015) in cancer patients: safety, feasibility and biological activity. Gene Ther. 2001;8(10):746–759. doi:10.1038/sj.gt.3301424.
   PubMed Web of Science ®Google Scholar
• Xia Z. J., Chang J. H., Zhang L., Jiang W. Q., Guan Z. Z., Liu J. W., Zhang Y., Hu X. H., Wu G. H., Wang H. Q., Chen Z. C., Chen J. C., Zhou Q. H., Lu J. W., Fan Q. X., Huang J. J., Zheng X. Phase III randomized clinical trial of intratumoral injection of E1B gene-deleted adenovirus (H101) combined with cisplatin-based chemotherapy in treating squamous cell cancer of head and neck or esophagus. Ai Zheng = Aizheng = Chinese Journal of Cancer. 2004; 23(12):1666–1670.
   PubMedGoogle Scholar
• Kimball, K. J., Preuss M. A., Barnes M. N., Wang M., Siegal G. P., Wan W., Kuo H., Saddekni S., Stockard C. R., Grizzle W. E., Harris R. D., Aurigemma R., Curiel D. T., Alvarez R. D. A phase I study of a tropism-modified conditionally replicative adenovirus for recurrent malignant gynecologic diseases. Clinical Cancer Research: an Official Journal of the American Association for Cancer Research. 2010;16(21):5277–5287. doi:10.1158/1078-0432.CCR-10-0791.
   PubMed Web of Science ®Google Scholar
• Ito, H., Aoki H., Kühnel F., Kondo Y., Kubicka S., Wirth T., Iwado E., Iwamaru A., Fujiwara K., Hess K. R., Lang F. F., Sawaya R., Kondo S. Autophagic cell death of malignant glioma cells induced by a conditionally replicating adenovirus. J Natl Cancer Inst. 2006;98(9):625–636. doi:10.1093/jnci/djj161.
   PubMedGoogle Scholar
• Rodriguez-Rocha H, Gomez-Gutierrez JG, Garcia-Garcia A, Rao XM, Chen L, McMasters KM, Zhou HS. Adenoviruses induce autophagy to promote virus replication and oncolysis. Virology. 2011;416(1–2):9–15. doi:10.1016/j.virol.2011.04.017.
   PubMed Web of Science ®Google Scholar
• Campbell GR, Bruckman RS, Chu YL, Spector SA. Autophagy induction by histone deacetylase inhibitors inhibits HIV type 1. J Biol Chem. 2015;290(8):5028–5040. doi:10.1074/jbc.M114.605428.
   PubMed Web of Science ®Google Scholar
• Yakoub AM, Shukla D. 2015. Autophagy stimulation abrogates herpes simplex virus-1 infection. Sci Rep. 5:9730. doi:10.1038/srep09730.
   PubMed Web of Science ®Google Scholar
• Zhang R, Chi X, Wang S, Qi B, Yu X, Chen JL. The regulation of autophagy by influenza A virus. Biomed Res Int. 2014;2014:498083.
   PubMed Web of Science ®Google Scholar
• Klein S, R, Piya S., Lu Z., Xia Y., Alonso M. M., White E. J., Wei J., Gomez-Manzano C., Jiang H., Fueyo J. C-Jun N-terminal kinases are required for oncolytic adenovirus-mediated autophagy. Oncogene. 2015. doi:10.1038/onc.2014.452.
   Web of Science ®Google Scholar
• Baird SK, Aerts JL, Eddaoudi A, Lockley M, Lemoine NR, McNeish IA. Oncolytic adenoviral mutants induce a novel mode of programmed cell death in ovarian cancer. Oncogene. 2008;27(22):3081–3090. doi:10.1038/sj.onc.1210977.
   PubMed Web of Science ®Google Scholar
• Gomez-Gutierrez JG, Nitz J, Sharma R, Wechman SL, Riedinger E, Martinez-Jaramillo E, Sam Zhou H, McMasters KM. 2016. Combined therapy of oncolytic adenovirus and temozolomide enhances lung cancer virotherapy in vitro and in vivo. Virology. 487:249–259. doi:10.1016/j.virol.2015.10.019.
   PubMed Web of Science ®Google Scholar
• Jiang H, White EJ, Rios-Vicil CI, Xu J, Gomez-Manzano C, Fueyo J. Human adenovirus type 5 induces cell lysis through autophagy and autophagy-triggered caspase activity. J Virol. 2011;85(10):4720–4729. doi:10.1128/JVI.02032-10.
   PubMed Web of Science ®Google Scholar
• Cheng PH, Rao XM, Duan X, Li XF, Egger ME, McMasters KM, Zhou HS. Virotherapy targeting cyclin E overexpression in tumors with adenovirus-enhanced cancer-selective promoter. J Mol Med. 2015;93(2):211–223. doi:10.1007/s00109-014-1214-6.
   PubMed Web of Science ®Google Scholar
• O’Shea C, Klupsch K, Choi S, Bagus B, Soria C, Shen J, McCormick F, Stokoe D. Adenoviral proteins mimic nutrient/growth signals to activate the mTOR pathway for viral replication. EMBO J. 2005;24(6):1211–1221. doi:10.1038/sj.emboj.7600597.
   PubMed Web of Science ®Google Scholar
• Cheng X, Liu H, Jiang CC, Fang L, Chen C, Zhang XD, Jiang ZW. Connecting endoplasmic reticulum stress to autophagy through IRE1/JNK/beclin-1 in breast cancer cells. Int J Mol Med. 2014;34(3):772–781. doi:10.3892/ijmm.2014.1822.
   PubMed Web of Science ®Google Scholar
• Pattingre S, Tassa A, Qu X, Garuti R, Liang XH, Mizushima N, Packer M, Schneider MD, Levine B. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell. 2005;122(6):927–939. doi:10.1016/j.cell.2005.07.002.
   PubMed Web of Science ®Google Scholar
• Debbas M, White E. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B. Genes Dev. 1993;7(4):546–554. doi:10.1101/gad.7.4.546.
   PubMed Web of Science ®Google Scholar
• Piya S, White EJ, Klein SR, Jiang H, McDonnell TJ, Gomez-Manzano C, Fueyo J. The E1B19K oncoprotein complexes with Beclin 1 to regulate autophagy in adenovirus-infected cells. PloS One. 2011;6(12):e29467. doi:10.1371/journal.pone.0029467.
   PubMed Web of Science ®Google Scholar
• Sui X., Chen R., Wang Z., Huang Z., Kong N., Zhang M., Han W., Lou F., Yang J., Zhang Q., Wang X., He C., Pan H. Autophagy and chemotherapy resistance: a promising therapeutic target for cancer treatment. Cell Death Dis. 2013;4:e838. doi:10.1038/cddis.2013.350.
   PubMed Web of Science ®Google Scholar
• Zhou YY, Li Y, Jiang WQ, Zhou LF. 2015. MAPK/JNK signalling: a potential autophagy regulation pathway. Bioscience Reports. 35:3. doi:10.1042/BSR20150111.
   Web of Science ®Google Scholar
• See RH, Shi Y. Adenovirus E1B 19,000-molecular-weight protein activates c-Jun N-terminal kinase and c-Jun-mediated transcription. Mol Cell Biol. 1998;18(7):4012–4022.
   PubMed Web of Science ®Google Scholar
• Sano R, Reed JC. ER stress-induced cell death mechanisms. Biochim Biophys Acta. 2013;1833(12):3460–3470. doi:10.1016/j.bbamcr.2013.06.028.
   PubMed Web of Science ®Google Scholar
• Rao XM, Tseng MT, Zheng X, Dong Y, Jamshidi-Parsian A, Thompson TC, Brenner MK, McMasters KM, Zhou HS. E1A-induced apoptosis does not prevent replication of adenoviruses with deletion of E1b in majority of infected cancer cells. Cancer Gene Ther. 2004;11(9):585–593. doi:10.1038/sj.cgt.7700739.
   PubMed Web of Science ®Google Scholar
• Han J, Sabbatini P, Perez D, Rao L, Modha D, White E. The E1B 19K protein blocks apoptosis by interacting with and inhibiting the p53-inducible and death-promoting Bax protein. Genes Dev. 1996;10(4):461–477. doi:10.1101/gad.10.4.461.
   PubMed Web of Science ®Google Scholar
• Jones N, Shenk T. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell. 1979;17(3):683–689.
   PubMed Web of Science ®Google Scholar
• Zheng X, Rao XM, Snodgrass C, Wang M, Dong Y, McMasters KM, Zhou HS. Adenoviral E1a expression levels affect virus-selective replication in human cancer cells. Cancer Biol Ther. 2005;4(11):1255–1262. doi:10.4161/cbt.4.11.2137.
   PubMed Web of Science ®Google Scholar
• Wechman SL, Rao XM, Cheng PH, Gomez-Gutierrez JG, McMasters KM, Zhou HS. 2016. Development of an oncolytic adenovirus with enhanced spread ability through repeated UV irradiation and cancer selection. Viruses. 8:6. doi:10.3390/v8060167.
   Web of Science ®Google Scholar
• Wechman SL, Rao XM, McMasters KM, Zhou HS. 2016. Adenovirus with DNA packaging gene mutations increased virus release. Viruses. 8:12. doi:10.3390/v8120333.
   PubMed Web of Science ®Google Scholar
• Cheng PH, Rao XM, Wechman SL, Li XF, McMasters KM, Zhou HS. 2015. Oncolytic adenovirus targeting cyclin E overexpression repressed tumor growth in syngeneic immunocompetent mice. BMC Cancer. 15:716. doi:10.1186/s12885-015-1584-3.
   PubMed Web of Science ®Google Scholar
• White E, Cipriani R. Specific disruption of intermediate filaments and the nuclear lamina by the 19-kDa product of the adenovirus E1B oncogene. Proc Natl Acad Sci U S A. 1989;86(24):9886–9890.
   PubMed Web of Science ®Google Scholar
• Zheng X, Rao XM, Gomez-Gutierrez JG, Hao H, McMasters KM, Zhou HS. Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication. J Virol. 2008;82(7):3415–3427. doi:10.1128/JVI.01708-07.
   PubMed Web of Science ®Google Scholar
• Li G, Xiang Y, Sabapathy K, Silverman RH. An apoptotic signaling pathway in the interferon antiviral response mediated by RNase L and c-Jun NH2-terminal kinase. J Biol Chem. 2004;279(2):1123–1131. doi:10.1074/jbc.M305893200.
   PubMed Web of Science ®Google Scholar
• Ishiyama M, Tominaga H, Shiga M, Sasamoto K, Ohkura Y, Ueno K. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull. 1996;19(11):1518–1520. doi:10.1248/bpb.19.1518.
   PubMed Web of Science ®Google Scholar
• Zheng X, Rao XM, Snodgrass CL, McMasters KM, Zhou HS. Selective replication of E1B55K-deleted adenoviruses depends on enhanced E1A expression in cancer cells. Cancer Gene Ther. 2006;13(6):572–583. doi:10.1038/sj.cgt.7700923.
   PubMed Web of Science ®Google Scholar
• Romanov VS, Brichkina AI, Morrison H, Pospelova TV, Pospelov VA, Herrlich P. Novel mechanism of JNK pathway activation by adenoviral E1A. Oncotarget. 2014;5(8):2176–2186. doi:10.18632/oncotarget.1860.
   PubMedGoogle Scholar
• Berk AJ. 1986. Adenovirus promoters and E1A transactivation. Annu Rev Genet. 20:45–79. doi:10.1146/annurev.ge.20.120186.000401.
   PubMed Web of Science ®Google Scholar
• Herrmann CH, Dery CV, Mathews MB. Transactivation of host and viral genes by the adenovirus E1B 19K tumor antigen. Oncogene. 1987;2(1):25–35.
   PubMed Web of Science ®Google Scholar
• Klein SR, Jiang H, Hossain MB, Fan X, Gumin J, Dong A, Alonso MM, Gomez-Manzano C, Fueyo J. Critical role of autophagy in the processing of adenovirus capsid-incorporated cancer-specific antigens. PloS One. 2016;11(4):e0153814. doi:10.1371/journal.pone.0153814.
   PubMed Web of Science ®Google Scholar
• Jiang H., Martin V., Gomez-Manzano C., Johnson D. G., Alonso M., White E., Xu J., McDonnell T. J., Shinojima N., Fueyo J. The RB-E2F1 pathway regulates autophagy. Cancer Res. 2010;70(20):7882–7893. doi:10.1158/0008-5472.CAN-10-1604.
   PubMed Web of Science ®Google Scholar
• Wang B, Ling S, Lin WC. 14-3-3Tau regulates Beclin 1 and is required for autophagy. PloS One. 2010;5(4):e10409. doi:10.1371/journal.pone.0010409.
   PubMed Web of Science ®Google Scholar
• Johnson DG, Degregori J. Putting the oncogenic and tumor suppressive activities of E2F into context. Curr Mol Med. 2006;6(7):731–738.
   PubMed Web of Science ®Google Scholar
• Oleinik NV, Krupenko NI, Krupenko SA. Cooperation between JNK1 and JNK2 in activation of p53 apoptotic pathway. Oncogene. 2007;26(51):7222–7230. doi:10.1038/sj.onc.1210526.
   PubMed Web of Science ®Google Scholar
• Okada M, Shibuya K, Sato A, Seino S, Watanabe E, Suzuki S, Seino M, Kitanaka C. Specific role of JNK in the maintenance of the tumor-initiating capacity of A549 human non-small cell lung cancer cells. Oncol Rep. 2013;30(4):1957–1964. doi:10.3892/or.2013.2655.
   PubMed Web of Science ®Google Scholar
• He XY, Chen JX, Ou-Yang X, Zhang Z, Peng HM. [Construction of let-7a expression plasmid and its inhibitory effect on k-Ras protein in A549 lung cancer cells]. Nan Fang Yi Ke Da Xue Xue Bao = Journal of Southern Medical University. 2010;30(11):2427–2431.
   PubMedGoogle Scholar
• Tazawa H, Kuroda S, Hasei J, Kagawa S, Fujiwara T. 2017. Impact of Autophagy in Oncolytic Adenoviral Therapy for Cancer. Int J Mol Sci. 18:7. doi:10.3390/ijms18071479.
   Web of Science ®Google Scholar